SCHEMBL6322720

SCHEMBL6322720

CCCC(C)CC(C(=O)O)N1CCc2ccccc21

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.44
SLC6A2 P23975 2/20 0.42
SLC6A4 P31645 2/20 0.42
ALDH1A1 P00352 6/20 0.41
GFER P55789 2/20 0.41
GAA P10253 1/20 0.41
NOTUM Q6P988 2/20 0.40
MAPT P10636 4/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
ACE P12821 1/20 0.40
LMNA P02545 1/20 0.40
TP53 P04637 1/20 0.40
TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14432541 0.88 SLC6A2 (0.46) POLBSLC6A2SLC6A4ALDH1A1GFER
SCHEMBL3372688 0.85 SLC6A2 (0.46) POLBSLC6A2SLC6A4ALDH1A1GFER
SCHEMBL11621424 0.83 SLC6A2 (0.48) POLBSLC6A2SLC6A4ALDH1A1GFER
SCHEMBL22381380 0.78 NPSR1 (0.48) POLBALDH1A1NOTUMMAPTHTT
SCHEMBL30530526 0.78 MAPT (0.55) POLBSLC6A2SLC6A4ALDH1A1GFER
SCHEMBL24421765 0.75 SLC6A2 (0.45) POLBSLC6A2SLC6A4ALDH1A1GFER
SCHEMBL4143391 0.75 GAA (0.55) POLBSLC6A2SLC6A4ALDH1A1GFER
SCHEMBL14557235 0.75 SLC6A2 (0.45) POLBSLC6A2SLC6A4ALDH1A1GFER
SCHEMBL7112322 0.75 NOTUM (0.50) POLBALDH1A1NOTUMHTTSMN1; SMN2
SCHEMBL3371630 0.75 NOTUM (0.49) POLBSLC6A2SLC6A4ALDH1A1GFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050154202-A1 Substituted aryl amides MERCK & CO., INC. 2005-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050154202-A1 Substituted aryl amides CNR1, CNR2, FAAH POLB 2454/4885SLC6A2 1641/4885SLC6A4 2261/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.